by Vandana Singh | Jun 15, 2026 | General
The U.S. Food and Drug Administration (FDA) on Friday cleared Dexcom Inc.‘s (NASDAQ:DXCM) Stelo Glucose Biosensor System for over-the-counter use in children ages 2 and older who do not use insulin, expanding access to continuous glucose monitoring for younger...
by Vandana Singh | Jun 15, 2026 | General
Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) stock is trading higher on Monday after the company reported preliminary results from an ongoing Phase 2 study evaluating setmelanotide in patients with Prader-Willi syndrome (PWS). The six-month data shared on Saturday showed...
by Vandana Singh | Jun 15, 2026 | General
AstraZeneca Plc (NYSE:AZN) received two significant regulatory updates from the U.S. Food and Drug Administration, with its cancer therapy Truqap gaining approval for a subset of prostate cancer patients and its kidney disease treatment Ultomiris receiving Priority...
by Vandana Singh | Jun 15, 2026 | General
Neumora Therapeutics Inc. (NASDAQ:NMRA) on Monday said it is discontinuing development of its lead depression candidate, navacaprant, after two Phase 3 studies failed to achieve statistical significance on both primary and key secondary endpoints in patients with...
by Benzinga Insights | Jun 15, 2026 | General
Seagate Technology Hldgs (NASDAQ:STX) has outperformed the market over the past 5 years by 50.85% on an annualized basis producing an average annual return of 63.62%. Currently, Seagate Technology Hldgs has a market capitalization of $226.32 billion. Buying $100 In...
by Evette Mitkov | Jun 15, 2026 | General
TeraWulf Inc (NASDAQ:WULF) shares are flying on Monday. BofA Securities initiated coverage on the stock with a Buy rating and a $34 price objective. Here’s what you should know. TeraWulf stock is at critical resistance. What’s behind WULF new highs? BofA Initiates...
Recent Comments